Table 5.
Adjusted Associationsa of dietary (DIS) and lifestyle (LIS) inflammation scores with incident colorectal cancer according to colorectal cancer site; the Iowa Women’s Health Study (n = 34,254), 1986 – 2012.
| Dietary inflammation scoreb | Lifestyle inflammation scorec | |||
|---|---|---|---|---|
| Colorectal site | Adjusted HR | 95% CI | Adjusted HR | 95% CI | 
| Proximal colond (n = 890) | ||||
| Continuous | 1.00 | 0.97, 1.03 | 1.16 | 1.06, 1.26 | 
| Quintiles | ||||
| 1 | 1.00 | Referent | 1.00 | Referent | 
| 2 | 0.85 | 0.69, 1.06 | 1.10 | 0.89, 1.36 | 
| 3 | 1.09 | 0.89, 1.33 | 1.16 | 0.92, 1.46 | 
| 4 | 0.97 | 0.78, 1.19 | 1.21 | 0.98, 1.50 | 
| 5 | 0.95 | 0.77, 1.18 | 1.43 | 1.16, 1.77 | 
| Ptrend | 0.96 | <0.01 | ||
| Pheterogeneity | 0.01 | 0.21 | ||
| Distal colone (n = 422) | ||||
| Continuous | 1.04 | 1.00, 1.09 | 1.24 | 1.09, 1.41 | 
| Quintiles | ||||
| 1 | 1.00 | Referent | 1.00 | Referent | 
| 2 | 0.90 | 0.64, 1.25 | 1.39 | 1.00, 1.94 | 
| 3 | 1.40 | 1.03, 1.90 | 1.68 | 1.20, 2.35 | 
| 4 | 1.10 | 0.80, 1.52 | 1.49 | 1.07, 2.06 | 
| 5 | 1.34 | 0.98, 1.84 | 1.78 | 1.29, 2.47 | 
| Ptrend | 0.03 | <0.01 | ||
| Pheterogeneity | 0.27 | 0.05 | ||
| Rectum (n = 236) | ||||
| Continuous | 1.00 | 0.95, 1.06 | 1.01 | 0.85, 1.19 | 
| Quintiles | ||||
| 1 | 1.00 | Referent | 1.00 | Referent | 
| 2 | 1.16 | 0.77, 1.75 | 1.16 | 0.78, 1.73 | 
| 3 | 0.95 | 0.61, 1.47 | 1.11 | 0.72, 1.70 | 
| 4 | 1.33 | 0.89, 2.00 | 1.06 | 0.70, 1.59 | 
| 5 | 1.18 | 0.77, 1.80 | 1.10 | 0.72, 1.67 | 
| Ptrend | 0.31 | 0.83 | ||
| Pheterogeneity | ref | ref | ||
Abbreviations: CI, confidence interval; HR, hazards ratio; ref, referent.
HRs and 95% CIs from Cox proportional hazards models.
For score construction, see text and Table 1; a higher score indicates a more proinflammatory diet; model covariates included age (years; continuous), education (< high school, high school, > high school and < college, ≥ college), family history of colorectal cancer in a first-degree relative (yes/no), smoking status (current, past, never smoker), alcohol use (servings/week; continuous), comorbidity score (sum of yes/no for diabetes, heart disease, and cirrhosis), hormone replacement therapy use (current, past, never), physical activity (low, medium, high), body mass index (weight [kg]/height [m]2; continuous), former smoker (yes/no), and total energy intake (kcal/day; continuous).
Includes current smoking (yes/no), physical activity, alcohol use, and body mass index; for score construction, see text; a higher score indicates a more proinflammatory lifestyle; model covariates included age (years; continuous), education (< high school, high school, > high school and < college, ≥ college), family history of colorectal cancer in a first-degree relative (yes/no), comorbidity score (includes sum of yes/no for diabetes, heart disease, and chronic colitis), hormone replacement therapy use (current, past, never use), former smoker (yes/no), total energy intake (kcal/day; continuous), and unweighted dietary inflammation score (DIS).
Includes cecum, ascending colon, hepatic flexure, and transverse colon.
Includes splenic flexure, descending colon, and sigmoid colon.